Technical Analysis for ALGS - Aligos Therapeutics, Inc.

Grade Last Price % Change Price Change
C 15.78 -0.19% -0.03
ALGS closed up 0.57 percent on Monday, September 27, 2021, on approximately normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Flat Flat
Historical ALGS trend table...

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish -0.19%
Bearish Engulfing Bearish 0.38%
Fell Below 50 DMA Bearish 0.38%
180 Bearish Setup Bearish Swing Setup 0.38%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.38%
Narrow Range Bar Range Contraction 0.38%
New Downtrend Bearish -0.38%
Crossed Above 50 DMA Bullish -0.38%
Outside Day Range Expansion -0.38%
Up 3 Days in a Row Strength -0.38%
Older End-of-Day Signals for ALGS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 2% about 2 hours ago
Rose Above 20 DMA about 3 hours ago
10 DMA Support about 3 hours ago
50 DMA Support about 3 hours ago
60 Minute Opening Range Breakout about 3 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of viral infections and liver diseases. Aligos is focused on the development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH). Aligos’ strategy is to harness the deep expertise and decades of drug development experience its workforce has in liver disease, particularly viral hepatitis, to rapidly advance its pipeline of potentially best-in-class molecules.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Alcohol Drug Development Coronavirus Hepatitis B Viruses Steatohepatitis Hepatitis Liver Disease Non Alcoholic Fatty Liver Disease Liver Diseases Viral Diseases Viral Infection Viral Infections Chronic Hepatitis Antiviral Therapies Chronic Hepatitis B

Is ALGS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 37.465
52 Week Low 12.82
Average Volume 238,591
200-Day Moving Average 22.92
50-Day Moving Average 15.76
20-Day Moving Average 16.08
10-Day Moving Average 15.84
Average True Range 0.87
ADX 25.35
+DI 12.98
-DI 23.29
Chandelier Exit (Long, 3 ATRs) 14.94
Chandelier Exit (Short, 3 ATRs) 17.10
Upper Bollinger Bands 17.34
Lower Bollinger Band 14.82
Percent B (%b) 0.39
BandWidth 15.66
MACD Line -0.15
MACD Signal Line -0.15
MACD Histogram -0.0012
Fundamentals Value
Market Cap 553.75 Million
Num Shares 35 Million
EPS
Price-to-Sales 0.00
Price-to-Book 5.43
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.61
Resistance 3 (R3) 16.57 16.28 16.47
Resistance 2 (R2) 16.28 16.07 16.29 16.43
Resistance 1 (R1) 16.04 15.95 16.16 16.08 16.38
Pivot Point 15.75 15.75 15.81 15.76 15.75
Support 1 (S1) 15.51 15.54 15.63 15.55 15.24
Support 2 (S2) 15.22 15.42 15.23 15.19
Support 3 (S3) 14.98 15.22 15.15
Support 4 (S4) 15.02